search
NASDAQ:MYGN
USD
24.52
- (1.1%)
MYRIAD GENETICS, INC.
Industry: Diagnostics & Research
End of Day: 24 June 2024 GMT-4
USD 24.52
- (1.1%)
End of Day: 24 June 2024 GMT-4
Industry: Diagnostics & Research

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the ca...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices